TrialJournal of Crohn's & colitis2026

Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group.

Catherine Reenaers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.